Document:

Exhibit 10.5

 Exhibit 10.5 
 AGREEMENT AND RELEASE 
 IT IS HEREBY AGREED by and between Jeffrey A. Rosolio (“Employee”)
and Integral Systems, Inc. (“ISI”), for the good and sufficient consideration set forth below, as follows: 
 1. Employee’s
employment will terminate by mutual agreement effective March 20, 2009 (the “date of separation”). Employee agrees to comply with ISI’s policies and procedures and, as requested by ISI, to continue to work and to perform all
duties in a professional and satisfactory manner and to provide assistance in the transition of Employee’s responsibilities through and including the date of separation. Subject to Employee’s compliance with these conditions and the
remaining provisions of this Agreement and Release, ISI agrees: 
 (a) to employ Employee through the date of separation; 
 (b) (i) to provide Employee with salary continuation at Employee’s current salary rate, minus applicable withholdings and deductions, from the
date following the date of separation through and including March 20, 2010 (the “Termination Coverage Period”) (for the avoidance of doubt, ISI shall have no right of set-off or deduction for any compensation received by Employee from
any third party during the Termination Coverage Period), (ii) to pay any Consolidated Omnibus Budget Reconciliation Act (“COBRA”) premiums during the Termination Coverage Period (or, if earlier, until COBRA coverage ends) for Employee
and Employee’s dependents if Employee (or, as applicable, Employee’s dependents) elects COBRA coverage; and (iii) to pay all accrued but unused vacation time through the date of separation; and 
 (c) to pay to Employee an annual bonus for the 2009 fiscal year, minus applicable withholdings and deductions, prorated for the period of employment in
such fiscal year through the date of separation (provided, however, that such bonus shall not be paid if ISI reasonably determines that Employee did not substantially meet, to the extent obtainable, his bonus-related goals as of the date of
separation), with such bonus to be paid at the time at which other similarly-situated ISI executives receive their bonus payments. 
 Employee’s
benefits will be governed by applicable plan terms. For the avoidance of doubt, with the exception of COBRA continuation coverage, Employee shall not be eligible for benefits during the Termination Coverage Period. (Employee may elect to continue
health insurance coverage, following the date of separation at Employee’s own expense, in accordance with the provisions of COBRA, regardless of whether Employee enters into this Agreement and Release.) Employee’s outstanding stock options
that are vested immediately prior the date of separation shall remain outstanding for ninety (90) days following the date of separation, and shall be forfeited and cancelled if not exercised before such 90th day. Employee’s outstanding
stock options that are not vested immediately prior the date of separation shall be forfeited and cancelled as of the date of separation and shall not be exercisable by Employee. 
 2. Employee acknowledges that, as of the date of Employee’s signing of this Agreement and Release, Employee has sustained no injury or illness
related in any way to Employee’s employment with ISI for which a workers compensation claim has not already been filed. 
 3. In return
for ISI’s agreement to provide Employee with the consideration referred to in Paragraph 1, Employee, for Employee and Employee’s heirs, beneficiaries, devisees, privies, executors, administrators, attorneys, representatives, and agents,
and Employee’s and their assigns, successors and predecessors, hereby releases and forever discharges ISI and its parents, subsidiaries and affiliates, its and their officers, directors, employees, members, agents, attorneys and
representatives, and the predecessors, 

 
successors and assigns of each of the foregoing (collectively, the “ISI Released Parties”) from any and all actions, causes of action, suits,
debts, claims, complaints, charges, contracts, controversies, agreements, promises, damages, counterclaims, cross-claims, claims for contribution and/or indemnity, claims for costs and/or attorneys’ fees, judgments and demands whatsoever, in
law or equity, known or unknown, Employee ever had, now has, or may have against the ISI Released Parties as of the date of Employee’s signing of this Agreement and Release. This release includes, but is not limited to, any claims alleging
breach of express or implied contract, wrongful discharge, constructive discharge, breach of an implied covenant of good faith and fair dealing, negligent or intentional infliction of emotional distress, negligent supervision or retention, violation
of the Age Discrimination in Employment Act, the Older Workers Benefit Protection Act, the Civil Rights Act of 1866, Title VII of the Civil Rights Act of 1964, the Americans with Disabilities Act, the Maryland Civil Rights Law, claims pursuant to
any other federal, state or local law regarding discrimination, harassment or retaliation based on age, race, sex, religion, national origin, marital status, disability, sexual orientation or any other unlawful basis or protected status or activity,
and claims for alleged violation of any other local, state or federal law, regulation, ordinance, public policy or common-law duty having any bearing whatsoever upon the terms and conditions of, and/or the cessation of Employee’s employment
with and by ISI. This release does not include claims that may not be released under applicable law and does not include any claims related to the obligations of ISI under this Agreement and Release. 
 ISI and its parents, subsidiaries and affiliates, and its and their predecessors, successors and assigns, hereby release and forever discharges Employee
and Employee’s heirs, beneficiaries, devisees, privies, executors, administrators, attorneys, representatives, and agents, and Employee’s and their assigns, successors and predecessors (collectively, the “Employee Released
Parties”) from any and all actions, causes of action, suits, debts, claims, complaints, charges, contracts, controversies, agreements, promises, damages, counterclaims, cross-claims, claims for contribution and/or indemnity, claims for costs
and/or attorneys’ fees, judgments and demands whatsoever, in law or equity, known or unknown, ISI ever had, now has, or may have against the Employee Released Parties as of the date of ISI’s signing of this Agreement and Release. This
release does not include claims that may not be released under applicable law and does not include any claims related to the obligations of Employee under this Agreement and Release. 
 4. Employee agrees not only to release and discharge the ISI Released Parties from any and all claims against the ISI Released Parties that Employee
could make on Employee’s own behalf, but also those which may have been or may be made by any other person or organization on Employee’s behalf. Employee specifically waives any right to become, and promises not to become, a member of any
class in a case in which any claim or claims are asserted against any of the ISI Released Parties based on any acts or omissions occurring on or before the date of Employee’s signing of this Agreement and Release. If Employee is asserted to be
a member of a class in a case against any of the ISI Released Parties based on any acts or omissions occurring on or before the date of Employee’s signing of this Agreement and Release, Employee shall immediately withdraw with prejudice in
writing from said class, if permitted by law to do so. Employee agrees that Employee will not encourage or assist any person in filing or pursuing any proceeding, action, charge, complaint, or claim against the ISI Released Parties, except as
required by law. 
 5. This Agreement and Release is not intended to interfere with Employee’s exercise of any protected, nonwaivable
right, including Employee’s right to file a charge with the Equal Employment Opportunity Commission or other government agency. By entering into this Agreement and Release, however, Employee acknowledges that the consideration set forth herein
is in full satisfaction and is inclusive of any and all amounts, including but not limited to attorneys’ fees, to which Employee might be entitled or which may be claimed by Employee or on Employee’s behalf against the ISI Released Parties
and Employee is forever discharging the ISI Released Parties from any liability to Employee for any acts or omissions occurring on or before the date of Employee’s signing of this Agreement and Release. 

 6. Neither this Agreement and Release, nor anything contained herein, shall be construed as an admission
by the ISI Released Parties of any liability or unlawful conduct whatsoever. The parties hereto agree and understand that the consideration set forth in Paragraph 1 is in excess of that which ISI is obligated to provide to Employee, and that it is
provided solely in consideration of Employee’s execution of this Agreement and Release. ISI and Employee agree that the consideration set forth in Paragraph 1 is sufficient consideration for the release being given by Employee in Paragraphs 3,
4 and 5, and for Employee’s other promises herein. 
 7. Employee will direct all requests for references to ISI’s Human Resources
Department, which will confirm Employee’s job title, dates of employment and Employee’s salary. Employee agrees to refrain from making statements that may reasonably be construed as negative or in any manner disparaging of the ISI Released
Parties. ISI agrees that its senior executives will refrain from making statements that may reasonably be construed as negative or in any manner disparaging of the Employee. 
 8. Employee agrees not to use, disclose to others, or permit anyone access to any of ISI’s trade secrets or confidential or proprietary information
without ISI’s express consent, and to return immediately to ISI all ISI property upon termination of Employee’s employment. Employee shall not retain any copy or other reproduction whatsoever of any ISI property after the termination of
Employee’s employment. In the absence of a material breach by ISI of its obligations under this Agreement and Release, Employee will also comply with the covenants in Section 5 of Employee’s Employment Agreement dated as of
November 19, 2007, as amended (the “Employment Agreement”). 
 9. Following the date of separation, Employee agrees to provide
such assistance and consulting services as ISI may reasonably request, provided that, if such assistance is requested after March 20, 2010, ISI provides reasonable compensation to Employee for time and expenses incurred in providing such
assistance to ISI. 
 10. Each party shall bear its own costs and attorneys’ fees, if any, incurred in connection with this Agreement
and Release. 
 11. This Agreement and Release contains the full agreement of the parties and may not be modified, altered, changed or
terminated except upon the express prior written consent of ISI and Employee or their authorized agents. It expressly supersedes all prior agreements and understandings between the parties with respect to its subject matter, including but not
limited to the Employment Agreement (other than the covenants applicable to Employee in Section 5 thereunder). 
 12. Employee
acknowledges and agrees that: (a) no promise or inducement for this Agreement and Release has been made except as set forth in this Agreement and Release; (b) this Agreement and Release is executed by Employee without reliance upon any
statement or representation by ISI except as set forth herein; (c) Employee is legally competent to execute this Agreement and Release and to accept full responsibility therefore; (d) Employee has been given twenty-one (21) days
within which to consider this Agreement and Release; (e) Employee has used all or as much of that twenty-one (21) day period as Employee deemed necessary to consider fully this Agreement and Release and, if Employee has not used the entire
twenty-one (21) day period, Employee waives that period not used; (f) Employee has read and fully understands the meaning of each provision of this Agreement and Release; (g) ISI has advised Employee to consult with an attorney
concerning this Agreement and Release; (h) Employee freely and voluntarily enters into this Agreement and Release; and (i) no fact, evidence, event, or transaction currently unknown to Employee but which may hereafter become known to
Employee shall affect in any manner the final and unconditional nature of the release stated above. 

 13. This Agreement and Release shall become effective and enforceable on the eighth (8th) day
following execution hereof by Employee unless Employee revokes it by so advising ISI in writing received by R. Miller Adams, General Counsel, at ISI’s offices at 5000 Philadelphia Way, Lanham, Maryland 20706 before the end of the seventh
(7th) day after its execution by Employee. 
 14. ISI and Employee agree that any dispute arising under or relating in any way to this
Agreement and Release will be submitted to arbitration in Baltimore, Maryland, in front of a single arbitrator, in accordance with the then-current employment dispute resolution rules of the American Arbitration Association, as the exclusive remedy
for such dispute, except that ISI reserves the right to seek preliminary or injunctive relief and/or appropriate equitable relief in a court of competent jurisdiction for violations by Employee of Paragraphs 7 or 8 of this Agreement and Release. ISI
and Employee agree that such arbitration will be confidential except that the parties may discuss the arbitration if required by law or as reasonably necessary to prosecute or defend the arbitration or to enforce any decision in such arbitration.
Any damages awarded in such arbitration shall be limited to the contract measure of damages, and shall not include punitive damages. To the extent permitted by law, all attorneys’ fees and costs associated with such arbitration, includingthe
cost of the arbitration (such as the Arbitrator’s fee), shall be borne by the non-prevailing party. 
 15. This Agreement and Release
shall be governed by and construed in accordance with the laws of the State of Maryland. 
 16. The waiver by any party of a breach of any
provision herein shall not operate or be construed as a waiver of any subsequent breach by any party. 
 17. The provisions of this agreement
are severable. Should any provision herein be declared invalid by a court or arbitrator of competent jurisdiction, the remainder of the agreement will continue in force, and the parties agree to renegotiate the invalidated provision in good faith to
accomplish its objective to the extent permitted by law. 
 18. This Agreement and Release may be signed in counterparts, and each
counterpart shall be considered an original agreement for all purposes. 
 19. This Agreement and Release shall be binding upon and inure to
the parties’ respective successors, assigns, heirs and personal representatives. 
 IN WITNESS WHEREOF, the parties have hereunto set
their hands. 
  

							
	 /s/ Jeffrey A. Rosolio
	 		 	 /s/ William M. Bambarger
	 	
	Jeffrey A. Rosolio	 		 	For Integral Systems, Inc.	 	
				
	  
	 		 	  
	 	
	Date	 		 	DateLetter Amendment

 Exhibit 10.30
 *** Text Omitted and Filed Separately 
 Confidential Treatment Requested 
 Under 17 C.F.R. §§ 200.80(b)(4) 
 and 17 C.F.R. 24b-2 
 

 
 January 2, 2009 
 Mr. Jon Berglund 
 Director of Corporate Accounts 
 Masimo Corporation 
 40 Parker Irvine, CA 92618 
  

	Re:	MS50662 Masimo Pulse Oximetry Agreement—Product Additions Dear Jon: 

 Masimo Corporation and Novation, LLC agree to amend Exhibit A to the Pulse Oximetry Agreement MS50662 by adding the 55 products as shown on the attachment effective April 1, 2009. These products will have a [...***...] percent
administrative fee. 
 All other terms and conditions of the Supplier Agreement shall remain the same. 
 Please indicate your agreement with the foregoing in the space provided below and return one signed original to the attention of David Hatch. 
 Sincerely, 
 /s/ Travis D. Johnson 
 Travis D. Johnson 
 Senior Director, Contract Services 
 Attachment 
 AGREED TO AND ACCEPTED this 30th day of January, 2009.

 Masimo Corporation 
  

			
		
	By:	 	/s/    Jim Beyer        
	Printed Name:	 	Jim Beyer
	Title:	 	V.P. Sales – Strategic Accounts

 * Confidential Treatment Requested 
  

 Page 1 of 4 

 ATTACHMENT TO ADDENDUM DATED JANUARY 2, 2009 
 FOR MASIMO AGREEMENT MS50662 
 PRODUCT
ADDITIONS EFFECTIVE APRIL 1, 2009 
  

															
	 Product
Number
	  	 Product Description
	  	UOM	  	Tier 1
[***]	  	Tier 2
[***]	  	Tier 3
[***]	  	Tier 4
[***]	  	Tier 5
[***]
								
	 2630
	  	Total Hemoglobin (SpHb) Parameter (*Early Adopter) (HW Life License)	  	EA	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]
								
	 2296H
	  	Carboxyhemoglobin (SpCO) Parameter (*Early Adopter) (HW Life License with SpHb)	  	EA	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]
								
	 2297H
	  	Methemoglobin (SpMet) Parameter (*Early Adopter) (HW Life License with SpHb)	  	EA	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]
								
	 2313H
	  	Pleth Variability Index (PVI) (*Early Adopter) (HW Life License with SpHb)	  	EA	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]
								
	 2633
	  	Total Hemoglobin (SpHb), 1-YR Term License	  	EA	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]
								
	 2631H
	  	Carboxyhemoglobin (SpCO) Parameter with SpHb, 1-YR Term License	  	EA	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]
								
	 2632H
	  	Methemoglobin (SpMet) Parameter with SpHb, 1-YR Term License	  	EA	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]
								
	 2631
	  	Carboxyhemoglobin (SpCO) without SpHb, Fixed Term License - 1 YR	  	EA	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]
								
	 2632
	  	Methemoglobin (SpMet) without SpHb, Fixed Term License - 1 YR	  	EA	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]
								
	 2635
	  	Pleth Variability Index (PVI) Parameter without SpHb, Fixed Term License - 1 YR	  	EA	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]
								
	 2297
	  	Methemoglobin (SpMet) Parameter without SpHb	  	EA	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]
								
	 2296
	  	Carboxyhemoglobin (SpCO) Parameter without SpHb	  	EA	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]
								
	 2313
	  	Pleth Variability Index (PVI) Software Upgrade without SpHb	  	EA	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]
								
	 2333
	  	Rainbow DCI, Continuous, Adult Reusable Sensor (SpHb, SpO2, SpCO and SpMet) 60 Hours, 1/box	  	EA	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]
								
	 2334
	  	Rainbow DCI-P, Continuous, Pediatric Reusable Sensor (SpHb, SpO2, SpCO and SpMet) 60 Hours, 1/box	  	EA	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]
								
	 2241
	  	Rainbow DC-3, Adult Reusable Direct Connect Sensor, 3 ft. (SpO2, SpCO, SpMet, SpHb) 60 Hours, 1/box	  	EA	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]
								
	 2242
	  	Rainbow DC-12, Adult Reusable Direct Connect Sensor, 12 ft. (Sp02, SpCO, SpMet, SpHb) 60 Hours, 1/box	  	EA	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]

 “Confidential Treatment Requested 
  

 Page 2 of 4 

															
	 Product
Number
	  	 Product Description
	  	UOM	  	Tier 1
[***]	  	Tier 2
[***]	  	Tier 3
[***]	  	Tier 4
[***]	  	Tier 5
[***]
								
	 2402
	  	Rainbow DCP-3, Pediatric Reusable Direct Connect Sensor, 3 ft. (SpO2, SpCO, SpMet, SpHb) 60 Hours, 1/box	  	EA	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]
								
	 2403
	  	Rainbow DCP-12, Pediatric Reusable Direct Connect Sensor, 12 ft. (SpO2, SpCO, SpMet, SpHb) 60 Hours, 1/box	  	EA	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]
								
	 2221
	  	Rainbow R25, Adult Adhesive Sensors (SpO2, SpCO and SpMet), 10/box	  	BX/10	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]
								
	 2222
	  	Rainbow R20, Pediatric Adhesive Sensors (SpO2, SpCO and SpMet), 10/box	  	BX/10	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]
								
	 2219
	  	Rainbow R25-L, Adult / Neonatal Adhesive Sensors (SpO2, SpCO and SpMet), 10/box	  	BX/10	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]
								
	 2220
	  	Rainbow R20-L, Infant Adhesive Sensors (SpO2, SpCO and SpMet),	  	BX/10	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]
								
	 2416
	  	Rainbow R1 R25, Adult Adhesive Sensors (SpO2, SpCO and SpMet), 10/box	  	BX/10	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]
								
	 2417
	  	Rainbow R1 R20, Pediatric Adhesive Sensors (SpO2, SpCO and SpMet), 10/box	  	EX/10	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]
								
	 2415
	  	Rainbow R1 R20-L, Infant Adhesive Sensors (SpO2, SpCO and SpMet), 10/box	  	BX110	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]
								
	 2414
	  	Rainbow R1 R25-L, Adult / Neonatal Adhesive Sensors (SpO2, SpCO and SpMet), 10/box	  	BX110	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]
								
	 2201
	  	Rainbow DCI-dc3, Adult Reusable Direct Connect Sensor, 3 ft. (SpO2, SpCO and SpMet), 1/box	  	EA	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]
								
	 2202
	  	Rainbow DCI-dc12, Adult Reusable Direct Connect Sensor, 12 ft. (SpO2, SpCO and SpMet), 1/box	  	EA	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]
								
	 2069
	  	Rainbow DCIP-dc3, Pediatric Reusable Direct Connect Sensor, 3 ft. (SpO2, SpCO and SpMet), 1/box	  	EA	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]
								
	 2070
	  	Rainbow DCIP-dc12, Pediatric Reusable Direct Connect Sensor, 12 ft. (SpO2, SpCO and SpMet), 1/box	  	EA	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]
								
	 2325
	  	RPC-01, Patient Cable, 1 ft. (Compatible w/LNCS or Rainbow Sensors), 1/box	  	EA	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]
								
	 2273
	  	RPC-04, Patient Cable, 4 ft. (Compatible w/ LNCS or Rainbow Sensors), 1/box	  	EA	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]
								
	 2274
	  	RPC-10, Patient Cable, 10 ft. (Compatible w/ LNCS or Rainbow Sensors), 1/box	  	EA	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]
								
	 2405
	  	RC-01, Patient Cable, 1 ft. , 1/box	  	EA	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]

 “Confidential Treatment Requested 
  

 Page 3 of 4 

															
	 Product
Number
	  	 Product Description
	  	UOM	  	Tier 1
[***]	  	Tier 2
[***]	  	Tier 3
[***]	  	Tier 4
[***]	  	Tier 5
[***]
								
	 2406
	  	RC-04, Patient Cable, 4 ft. , 1/box	  	EA	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]
								
	 2404
	  	RC-12, Patient Cable, 12 ft. , 1/box	  	EA	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]
								
	 2323
	  	Replacement Tapes for Rainbow R20-L, 100/box	  	BX/100	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]
								
	 2324
	  	Replacement Tapes for Rainbow R25-L, 100/box	  	BX/100	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]
								
	 2291
	  	Rainbow Adult / Neo Sensor Sample Pack, 1-R25, 1-R25-L	  	PK/1	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]
								
	 2292
	  	Rainbow Ped / lnf Sensor Sample Pack, 1-R20, 1-R20-L	  	PK/1	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]
								
	 9086
	  	Configurable, Radical-7 Handheld, Color Screen	  	EA	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]
								
	 9153
	  	Configurable, Radical-7 Handheld, Blue Screen	  	EA	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]
								
	 2297
	  	Methemoglobin (SpMet), Parameter	  	EA	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]
								
	 2296
	  	Carboxyhemoglobin (SpCO), Parameter	  	EA	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]
								
	 2313
	  	Pleth Variability Index (PVI), Parameter	  	EA	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]
								
	 9081
	  	Field Upgrader, Deposit (Refunded upon return to Masimo)	  	EA	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]
								
	 9061
	  	Rad-57c Portable CO-Oximeter with SpO2 and SPCO , World Wide, with Rainbow DCI-dc3 or DCIP-dc3 and Case or Boot (FKA PN#2050)	  	EA	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]
								
	 9063
	  	Rad-57m Portable CO-Oximeter with SpO2 and SpMet, World Wide, with Rainbow DCI-dc3 or DCIP-dc3 and Case or Boot (FKA PN# 2205)	  	EA	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]
								
	 9062
	  	Rad-57cm Portable CO-Oximeter with SpO2, SpCO and SpMet, with Rainbow DCI-dc3 or DCIP-dc3 and Case or Boot (FKA PN#2200)	  	EA	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]
								
	 2339
	  	Rad-57, Upgrade (Rad-57c or Rad-57m to Rad-57cm)	  	EA	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]
								
	 2063
	  	Rad-57 PRONTO Trend download serial cable	  	EA	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]
								
	 31740
	  	Operator’s Manual, Rad-57	  	EA	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]
								
	 2207
	  	Water Resistant Handheld Carrying Case, Black	  	EA	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]
								
	 2208
	  	Water Resistant Handheld Carrying Case, Red	  	EA	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]

 “ Confidential Treatment Requested 
  

 Page 4 of 4

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00158-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00158-of-00352.parquet"}]]